CTO Conference 2018
About the CTO 2018 Clinical Trials Conference
On March 27 and 28, 2018, Clinical Trials Ontario brought together members of the clinical research community through an exciting conference program aimed at understanding and addressing the challenges and opportunities to support a strong environment for clinical trials and the health and economic benefits they bring to Ontarians.
View the CTO 2018 Clinical Trials Conference program.
Learn about the speakers who presented at the CTO 2018 Clinical Trials Conference.
See the agenda from March 26th – No Site Left Behind Pre-Conference Workshop on trial site activation.
To view two of the panel discussion sessions conducted at the CTO 2018 Clinical Trials Conference, please click the videos below.
Review select presentations:
- Ken Getz, Director, Sponsored Research Programs and Research Associate Professor, Tufts Center for the Study of Drug Development (Keynote Speaker) Anticipating Patient Engagement’s Impact on the Evolution of Clinical Research
- Zayna Khayet, Future Strategist, Saint Elizabeth, Health: From Cost Center to Wealth Creator
- Bev Heim-Myers, CEO, Huntington Society of Canada Making it Easier for Patients to Understand and Participate in Clinical Trials
- John-Peter Bradford, CEO, Life Saving Therapies Network How Clinical Trial Reform Can Help People With Lethal Diseases Extend Their Lives and Live Well
- Michelle Greiver, Acting Director, University of Toronto Practice-Based Research Network (UTOPIAN), Adjunct Scientist, Institute for Clinical Evaluative Sciences Finding out About Trials in Family Medicine: How Practice Based Research Networks and their Data Can Help
- Kirby Kim, Caregiver Representative and Contributing Member, Neuroblastoma Canada Navigating Through Neuroblastoma and Therapy Induced Myelodysplastic Syndrome
- Sarah Khan, Patient Education & Support Manager, Ontario Region, The Leukemia & Lymphoma Society Canada Clinical Trial Support Centre Services: Patient Experiences Using the Information Resource Center
- Barry Stein, President and CEO, Colorectal Cancer Canada Patient Group Pathway Model to Accessing Cancer Clinical Trials in Canada
- Ken Bond, Director, Patient Engagement, Ethics and International Affairs, Canadian Agency for Drugs and Technology Health Including Patients in the CADTH Scientific Advice Program: Ask, Listen, Advise
- Roslyn Schneider, Global Patient Affairs Leader, Pfizer Chamber Music to Symphony: Integrating Patient Community Insights in Medicine Development Through a Cycle of Internal and External Engagement
- Chantal Lacasse, Senior Clinical Operations Manager, Clinical Research, AbbVie Patient Engagement and a Clinical Study in the Making—From Theory to Practice
- Julia Abelson, Professor, Health Research Methods, Evidence, and Impact, McMaster University Advancing the Science of Patient Engagement Through Evaluation
- Joshua Shaw, Health Privacy Policy Analyst, Regulating the Use of Personal Health Information in Big Data Research
- Lauren Kelly, Clinical Trialist, George & Fay Yee Centre for Healthcare Innovation & Assistant Professor, Department of Pediatrics & Child Health, University of Manitoba, Innovative Approaches to Multi-site Academic Clinical Trials in Canada: the Power of Partnerships
- Holly Longstaff, Research Privacy Advisor, Provincial Health Services Authority, Ethicist, BC Cancer Research Ethics Board, Streamlining the Review and Resolution of Privacy Issues
